AN ESTIMATE OF THE COST OF IN-VITRO FERTILIZATION SERVICES IN THE UNITED-STATES IN 1995
AN ESTIMATE OF THE COST OF IN-VITRO FERTILIZATION SERVICES IN THE UNITED-STATES IN 1995
复制标题
DOI：
10.1016/s0015-0282(16)57789-9
复制
发表时间：
1995-09-01
影响因子：
6.7
通讯作者：
LAWRENCE, LD
中科院分区：
文献类型：
--
作者：
COLLINS, JA;BUSTILLO, M;LAWRENCE, LD
目的：评估将体外受精治疗添加到标准医疗福利方案中的成本。体外受精费用被定义为现有试管受精计划中单个治疗周期的平均费用。设计：成本分析。背景：1993年美国活跃的260个试管受精中心。主要观察指标：1993年试管受精的利用率和结果根据现有登记的数据估计。体外受精费用是根据1993年对试管受精诊所的调查确定的。由此产生的福利和保费支出预计为1945年，如果使用率增加300%或500%，则增加的费用。结果：1993年美国有31,718个试管婴儿周期，平均费用为6,233美元，导致1993年试管婴儿服务的总支出约为1.477亿美元。1945年，在典型的雇主健康计划中增加试管受精服务的预计成本为每年2.79美元，保费为3.14美元。使用率提高300%的福利和保费成本分别为8.37美元和9.41美元，增加500%的福利和保费成本分别为13.95美元和15.69美元。结论：试管受精服务的成本将是典型家庭福利计划年成本(3393美元)的极小部分。减少使用替代疗法所节省的费用将部分抵消这一增长。使用率的提高应由临床标准控制。
Objective: To estimate the cost of adding IVF treatment to a standard health care benefits package. In vitro fertilization cost is defined as the average charge for a single cycle of treatment in an existing IVF program.Design: Cost analysis.Setting: Two hundred sixty IVF centers active in the United States in 1993.Main Outcome Measures: In vitro fertilization utilization and outcomes for 1993 were estimated from data in an existing registry. In vitro fertilization charges were determined from a 1993 survey of IVF clinics. The resulting expenditures for benefits and premiums were projected to 1945 together with the additional cost if utilization were to increase by 300% or 500%.Results: In the United States in 1993 there were 31,718 IVF cycles for which the average charge was $6,233, leading to a total expenditure of approximately $147.70 million for IVF services in 1993. The projected cost of adding IVF services to a typical employer health plan in 1945 would be $2.79 per annum and the premium would be $3.14. Benefits and premium costs for a 300% utilization increase were $8.37 and $9.41, respectively, and for a 500% increase, $13.95 and $15.69, respectively.Conclusions: The cost of IVF services would be a minute fraction of the annual cost of a typical family benefits program ($3,393). Savings from reduced utilization of alternative treatments would offset a portion of this increase. Increases in utilization rates should be controlled by clinical criteria.